- Home
- LAMR vs BMRN Comparison
LAMR vs BMRN Comparison
Compare LAMR & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAMR
- BMRN
- Stock Information
- Founded
- LAMR 1902
- BMRN 1996
- Country
- LAMR United States
- BMRN United States
- Employees
- LAMR N/A
- BMRN N/A
- Industry
- LAMR Real Estate Investment Trusts
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- LAMR Real Estate
- BMRN Health Care
- Exchange
- LAMR Nasdaq
- BMRN Nasdaq
- Market Cap
- LAMR 12.1B
- BMRN 12.1B
- IPO Year
- LAMR 1996
- BMRN 1999
- Fundamental
- Price
- LAMR $125.07
- BMRN $58.00
- Analyst Decision
- LAMR Buy
- BMRN Buy
- Analyst Count
- LAMR 6
- BMRN 22
- Target Price
- LAMR $131.83
- BMRN $93.43
- AVG Volume (30 Days)
- LAMR 572.0K
- BMRN 2.2M
- Earning Date
- LAMR 08-08-2025
- BMRN 08-04-2025
- Dividend Yield
- LAMR 4.95%
- BMRN N/A
- EPS Growth
- LAMR N/A
- BMRN 152.82
- EPS
- LAMR 4.11
- BMRN 2.71
- Revenue
- LAMR $2,220,416,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- LAMR $4.78
- BMRN $12.27
- Revenue Next Year
- LAMR $3.54
- BMRN $9.99
- P/E Ratio
- LAMR $30.57
- BMRN $21.48
- Revenue Growth
- LAMR 3.72
- BMRN 19.36
- 52 Week Low
- LAMR $99.84
- BMRN $52.93
- 52 Week High
- LAMR $139.88
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- LAMR 63.21
- BMRN 59.75
- Support Level
- LAMR $121.89
- BMRN $56.76
- Resistance Level
- LAMR $129.78
- BMRN $59.98
- Average True Range (ATR)
- LAMR 2.97
- BMRN 1.44
- MACD
- LAMR 0.24
- BMRN 0.62
- Stochastic Oscillator
- LAMR 59.86
- BMRN 81.47
About LAMR Lamar Advertising Company
Lamar Advertising Co is an outdoor advertising companies in the United States and operates as a Real Estate Investment Trust. It rent space for advertising on billboards, buses, shelters, benches, logo plates and in airport terminals and also offer customers a fully integrated service with all aspects of their display requirements from ad copy production to placement and maintenance. It has two operating segments: billboard and Others. Key revenue is generated from Billboard segment.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.